| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |